Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
RANKL inhibits macrophage proinflammatory Toll-like receptor 2 and 4 signaling and impairs killing of intracellular bacteria.
PMID 42177796 · PMC13198865 · ImmunoHorizons · 2026 · 8 claims · 8 setups
Prior RANKL exposure increases intracellular Salmonella Typhimurium (STm) burden in mouse and human macrophages
-
Full-text index only
A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2.
PMID 41876554 · PMC13172340 · NPJ vaccines · 2026 · 8 claims · 8 setups
The G1-C mRNA vaccine (RBD + membrane protein epitope) induces 8.2-fold higher WA1 RBD-specific IgG and 16.6-fold higher XBB.1.5 RBD-specific IgG than the RBD-only vaccine
-
Has reproduction · 87
Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women.
PMID 40661959 · PMC12257036 · Frontiers in immunology · 2025 · 7 claims · 5 setups
NK cells show a sustained reduction during active SARS-CoV-2 infection and persisting after recovery in pregnant women
-
Full-text index only
Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound.
PMID 41864210 · PMC13245417 · Immunity · 2026 · 8 claims · 8 setups
Delayed HIV rebound after ART interruption is not consistently associated with levels of intact HIV provirus across cohorts
-
Full-text index only
Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7.
PMID 41920738 · PMC13222646 · Cell reports · 2026 · 8 claims · 8 setups
NT-I7 preferentially expands PD-1+TCF1+Tim-3- stem-like virus-specific CD8 T cells rather than effector/TD subsets during chronic LCMV infection
-
Full-text index only
Vitamin C Conditioning Generates Tumor-Targeting CAR T Cells with Superior Cytotoxicity and Fitness in a Posttransplant Lymphoproliferative Disorder Tumor Model.
PMID 41416402 · PMC13136873 · Molecular cancer therapeutics · 2026 · 8 claims · 8 setups
VitC conditioning enhances transduction efficiency and proliferative capacity, yielding a higher yield of CD4+ and CD8+ CAR19-Ts